Cross-cultural study finds health tech and advertising popular with Hispanic community, amid generational shifts – Endpoints News
Sanofi is looking outside for advice and accountability on its diversity, equity and inclusion initiatives. Three of the board members on its newly created Sanofi DE&I Board aren’t employed by the company – an unusual move Sanofi says is a pharma-industry first.
John Amaechi, a psychologist, former NBA player and best-selling author; Caroline Casey, a pioneer for disability inclusion and founder of The Valuable 500; and Rohini Anand, a global DEI thought leader and consultant, will sit on the 11-person Sanofi board. CEO Paul Hudson and R&D chief John Reed are among the six Sanofi executive team members on the new board which is chaired by chief diversity, culture and experience officer Raj Verma.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 138,000+ biopharma pros reading Endpoints daily — and it’s free.